Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 9350-9360

  Cormier, Stephania A ^a   Shrestha, Bishwas ^a   Saravia, Jordy ^a   Lee, Greg I ^a   Shen, Li ^b   DeVincenzo, John P ^a,c   Kim, Young In ^a   You, Dahui ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b HUNAN NORMAL UNIVERSITY   (China)

^c LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 4 RECEPTOR ALPHA; RECOMBINANT ALPHA INTERFERON A;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG MECHANISM; IMMUNOPATHOGENESIS; MOUSE; NEWBORN; NEWBORN INFECTION; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REINFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH2 CELL; VIRUS LOAD;

ANIMALS; DENDRITIC CELLS; HUMANS; INTERFERON-ALPHA; LUNG; MICE; MICE, INBRED BALB C; RECEPTORS, CELL SURFACE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TH2 CELLS; VERO CELLS; VIRAL LOAD;

EID: 84904891710     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00818-14     Document Type: Article

References (34)

1. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, Gustafsson PM. 2010. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65: 1045-1052. http://dx.doi.org/10.1136/thx.2009.121582.
2. Paramore LC, Ciuryla V, Ciesla G, Liu L. 2004. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 22:275-284. http://dx.doi.org/10.2165/00019053-200422050-00001.
3. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
4. You D, Marr N, Saravia J, Shrestha B, Lee GI, Turvey SE, Brombacher F, Herbert DR, Cormier SA. 2013. IL-4Ralpha on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates. J. Leukoc. Biol. 93:933-942. http://dx.doi.org/10.1189/jlb.1012498.
5. Cormier SA, You D, Honnegowda S. 2010. The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev. Anti Infect. Ther. 8:1371-1380. http://dx.doi.org/10.1586/eri.10.125.
6. Ripple MJ, You D, Honnegowda S, Giaimo JD, Sewell AB, Becnel DM, Cormier SA. 2010. Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease. J. Immunol. 185:4804-4811. http://dx.doi.org/10.4049/jimmunol.1000484.
7. You D, Becnel D, Wang K, Ripple M, Daly M, Cormier SA. 2006. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir. Res. 7:107. http://dx.doi.org/10.1186/1465-9921-7-107.
8. Culley FJ, Pollott J, Openshaw PJ. 2002. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 196:1381-1386. http://dx.doi.org/10.1084/jem.20020943.
9. Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, Takeda K, Gelfand EW. 2005. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J. Immunol. 175:1876-1883. http://dx.doi.org/10.4049/jimmunol.175.3.1876.
10. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195: 1126-1136. http://dx.doi.org/10.1086/512615.
11. Hoebee B, Rietveld E, Bont L, Oosten M, Hodemaekers HM, Nagelkerke NJ, Neijens HJ, Kimpen JL, Kimman TG. 2003. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J. Infect. Dis. 187:2-11. http://dx.doi.org/10.1086/345859.
12. Puthothu B, Krueger M, Forster J, Heinzmann A. 2006. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J. Infect. Dis. 193:438-441. http://dx.doi.org/10.1086/499316.
13. Hornung V, Schlender J, Guenthner-Biller M, Rothenfusser S, Endres S, Conzelmann KK, Hartmann G. 2004. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a singlestranded RNA virus. J. Immunol. 173:5935-5943. http://dx.doi.org/10.4049/jimmunol.173.10.5935.
14. Johnson TR, Johnson CN, Corbett KS, Edwards GC, Graham BS. 2011. Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PLoS One 6:e16458. http://dx.doi.org/10.1371/journal.pone.0016458.
15. Boogaard I, van Oosten M, van Rijt LS, Muskens F, Kimman TG, Lambrecht BN, Buisman AM. 2007. Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells. Immunology 122:65-72. http://dx.doi.org/10.1111/j.1365-2567.2007.02613.x.
16. Smit JJ, Lindell DM, Boon L, Kool M, Lambrecht BN, Lukacs NW. 2008. The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS One 3:e1720. http://dx.doi.org/10.1371/journal.pone.0001720.
17. Smit JJ, Rudd BD, Lukacs NW. 2006. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203:1153-1159. http://dx.doi.org/10.1084/jem.20052359.
18. Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS, Jr, Bakaletz LO, Durbin RK, Flano E, Durbin JE. 2007. Differential type I interferon induction by respiratory syncytial virus and influenza A virus in vivo. J. Virol. 81:9790-9800. http://dx.doi.org/10.1128/JVI.00530-07.
19. Guerrero-Plata A, Baron S, Poast JS, Adegboyega PA, Casola A, Garofalo RP. 2005. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J. Virol. 79: 10190-10199. http://dx.doi.org/10.1128/JVI.79.16.10190-10199.2005.
20. Gill MA, Palucka AK, Barton T, Ghaffar F, Jafri H, Banchereau J, Ramilo O. 2005. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J. Infect. Dis. 191:1105-1115. http://dx.doi.org/10.1086/428589.
21. McIntosh K. 1978. Interferon in nasal secretions from infants with viral respiratory tract infections. J. Pediatr. 93:33-36. http://dx.doi.org/10.1016/S0022-3476(78)80595-2.
22. Marr N, Wang TI, Kam SH, Hu YS, Sharma AA, Lam A, Markowski J, Solimano A, Lavoie PM, Turvey SE. 2014. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J. Immunol. 192:948-957. http://dx.doi.org/10.4049/jimmunol.1302007.
23. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
24. McKimm-Breschkin JL. 2004. A simplified plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. J. Virol. Methods 120:113-117. http://dx.doi.org/10.1016/j.jviromet.2004.02.020.
25. Boukhvalova MS, Yim KC, Prince GA, Blanco JC. 2010. Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: detection of abortive viral replication. Curr. Protoc. Cell Biol. Chapter 26:Unit 26.6. http://dx.doi.org/10.1002/0471143030.cb2606s46.
26. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78:4363-4369. http://dx.doi.org/10.1128/JVI.78.8.4363-4369.2004. (Erratum, 78:6705, http://dx.doi.org/10.1128/JVI.78.12.6705.2004.)
27. Zucchini N, Bessou G, Robbins SH, Chasson L, Raper A, Crocker PR, Dalod M. 2008. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organspecific manner during viral infection. Int. Immunol. 20:45-56. http://dx.doi.org/10.1093/intimm/dxm119.
28. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, Vicari A, O'Garra A, Biron C, Briere F, Trinchieri G. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:1144-1150. http://dx.doi.org/10.1038/ni736.
29. Villadangos JA, Young L. 2008. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29:352-361. http://dx.doi.org/10.1016/j.immuni.2008.09.002.
30. Ruckwardt TJ, Malloy AM, Gostick E, Price DA, Dash P, McClaren JL, Thomas PG, Graham BS. 2011. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. PLoS Pathog. 7:e1002377. http://dx.doi.org/10.1371/journal.ppat.1002377.
31. Brinkmann V, Geiger T, Alkan S, Heusser CH. 1993. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 178:1655-1663. http://dx.doi.org/10.1084/jem.178.5.1655.
32. Pene J, Rousset F, Briere F, Chretien I, Bonnefoy JY, Spits H, Yokota T, Arai N, Arai K, Banchereau J. 1988. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. U. S. A. 85:6880-6884. http://dx.doi.org/10.1073/pnas.85.18.6880.
33. Sung RY, Yin J, Oppenheimer SJ, Tam JS, Lau J. 1993. Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a. Arch. Dis. Child. 69:440-442. http://dx.doi.org/10.1136/adc.69.4.440.
34. Portnoy J, Hicks R, Pacheco F, Olson L. 1988. Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus. Antimicrob. Agents Chemother. 32:589-591. http://dx.doi.org/10.1128/AAC.32.4.589.